Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $135,475 | 64 | 99.8% |
| Food and Beverage | $280.80 | 17 | 0.2% |
| Travel and Lodging | $19.14 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $122,280 | 56 | $0 (2024) |
| Shire North American Group Inc | $13,214 | 9 | $0 (2019) |
| Greenwich Biosciences, Inc. | $211.02 | 13 | $0 (2021) |
| Kyowa Kirin, Inc. | $49.27 | 3 | $0 (2021) |
| CSL Behring | $20.51 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,360 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($27,360) |
| 2023 | $18,040 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($18,040) |
| 2022 | $26,160 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($26,160) |
| 2021 | $25,855 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($25,760) |
| 2020 | $25,086 | 20 | Takeda Pharmaceuticals U.S.A., Inc. ($24,960) |
| 2019 | $13,275 | 12 | Shire North American Group Inc ($13,214) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 08/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 06/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 05/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 04/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 03/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 12/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 11/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 10/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 09/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 07/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 06/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 04/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 02/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 12/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 11/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 10/05/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 09/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| 08/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 23 | 23 | $866.60 | $171.91 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 73502 | X-ray of hip with pelvis, 2-3 views | Facility | 2020 | 11 | 11 | $440.00 | $94.95 | 21.6% |
| 73560 | X-ray of knee, 1 or 2 views | Facility | 2020 | 12 | 12 | $426.60 | $76.96 | 18.0% |
About Dr. Matthew Cherry, D.O
Dr. Matthew Cherry, D.O is a Diagnostic Radiology healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457376865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Cherry, D.O has received a total of $135,775 in payments from pharmaceutical and medical device companies, with $27,360 received in 2024. These payments were reported across 82 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($135,475).
As a Medicare-enrolled provider, Cherry has provided services to 23 Medicare beneficiaries, totaling 23 services with total Medicare billing of $171.91. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Springfield, MO
- Active Since 07/13/2006
- Last Updated 09/26/2016
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1457376865
Products in Payments
- Epidiolex (Drug) $211.02
- NOURIANZ (Drug) $49.27
- Hizentra (Biological) $20.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Springfield
Kimberley Prater, M.d, M.D
Diagnostic Radiology — Payments: $1.7M
Ronald Hidalgo, Md, MD
Diagnostic Radiology — Payments: $236,483
Charles Mcglade, Md, MD
Diagnostic Radiology — Payments: $96,626
Ambarish Bhat, M.d, M.D
Diagnostic Radiology — Payments: $9,211
Anna Kuhn, Md, MD
Diagnostic Radiology — Payments: $5,044
Dr. Julie Alford, Md, MD
Diagnostic Radiology — Payments: $3,818